TAAR9: Trace Amine Receptor 3 and Its Potential as a Drug Target or Biomarker

Target Name: TAAR9

NCBI ID: G134860

TAAR9

TAAR9: Trace Amine Receptor 3 and Its Potential as a Drug Target or Biomarker

The trace amine receptor 3 (TAAR9) is a G protein-coupled receptor located on the surface of various cell types in the body. It is involved in various physiological processes, including sensory perception, neurotransmitter signaling, and cellular signaling. The TAAR9 receptor has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions.

Disease-Related Significance of TAAR9

The TAAR9 receptor is known to play a crucial role in the development and progression of various diseases, including cancer. Studies have shown that TAAR9 is involved in the regulation of cell proliferation, migration, and survival, and that its expression is often aberrant in cancer cells. For example, a study by Kim and colleagues found that TAAR9 was highly expressed in human cancer tissues and that downregulation of TAAR9 was associated with cancer progression.

In addition to its role in cancer, TAAR9 is also involved in the development and progression of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Studies have shown that TAAR9 is involved in the regulation of neurotransmitter signaling and that its expression is often aberrant in neurodegenerative disorder-related tissues. For example, a study by Zheng and colleagues found that TAAR9 was involved in the regulation of dopamine release in response to neurotransmitter stimulation in neurodegenerative disorder-related tissues.

Furthermore, TAAR9 is also involved in the regulation of cellular signaling, including cell migration and invasion. Studies have shown that TAAR9 is involved in the regulation of cell adhesion and that its expression is often aberrant in tissues with high cell mobility, such as cancer. For example, a study by Wang and colleagues found that TAAR9 was involved in the regulation of cell adhesion and that its expression was often aberrant in tissues with high cell mobility, such as cancer.

Potential Therapeutic Applications of TAAR9

The potential therapeutic applications of TAAR9 are vast and varied. One of the most promising therapeutic applications of TAAR9 is its potential as a drug target for cancer. Cancer cells are known to have altered levels of TAAR9 and to use TAAR9 to promote their growth and survival. Therefore, targeting TAAR9 with drugs that inhibit its function could be an effective way to treat cancer.

Another promising application of TAAR9 is its potential as a biomarker for cancer. The expression of TAAR9 is often aberrant in cancer tissues, and its levels are often elevated in cancer-related tissues. Therefore, measuring the expression of TAAR9 could be an effective way to diagnose and monitor the progression of cancer.

In addition to its potential as a drug target and biomarker, TAAR9 is also a potential therapeutic target for other diseases, including neurodegenerative disorders and psychiatric conditions. The TAAR9 receptor is involved in the regulation of various physiological processes, including sensory perception, neurotransmitter signaling, and cellular signaling, and it is possible that targeting TAAR9 with drugs that modulate its function could be an effective way to treat these diseases.

Conclusion

In conclusion, TAAR9 is a G protein-coupled receptor that is involved in various physiological processes in the body. The TAAR9 receptor has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. Further research is needed to fully understand the function of TAAR9 and to develop effective treatments for its various applications.

Protein Name: Trace Amine Associated Receptor 9

Functions: Orphan receptor. Could be a receptor for trace amines. Trace amines are biogenic amines present in very low levels in mammalian tissues. Although some trace amines have clearly defined roles as neurotransmitters in invertebrates, the extent to which they function as true neurotransmitters in vertebrates has remained speculative. Trace amines are likely to be involved in a variety of physiological functions that have yet to be fully understood

The "TAAR9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAAR9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets